INSIDER · CIK 2156365
Keller Eric L.
CHIEF EXECUTIVE OFFICER, Director at Retension Pharmaceuticals, Inc. (RTSN)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$250KBought on the market
$0.00Sold on the market
1Companies
Oct 13, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 202618:12 | Oct 13, 2026 | RTSNRetension Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER, Director | P · Buy | $12.00 | +20,800 | 423,377 | +5% | +$250K | +6.0% | -1.4% |
| Oct 13, 202618:12 | Oct 13, 2026 | RTSNRetension Pharmaceuticals, Inc. | CHIEF EXECUTIVE OFFICER, Director | C · Convert | — | +41,030 | 464,407 | +10% | — |